Financials data is unavailable for this security.
View more
Year on year Medivir AB grew revenues 73.16% from 4.41m to 7.63m while net income improved from a loss of 88.77m to a smaller loss of 89.32m.
Gross margin | -1,152.23% |
---|---|
Net profit margin | -1,550.15% |
Operating margin | -1,604.19% |
Return on assets | -48.26% |
---|---|
Return on equity | -65.40% |
Return on investment | -61.14% |
More ▼
Cash flow in SEKView more
In 2023, Medivir AB increased its cash reserves by 44.35%, or 52.08m. Cash Flow from Financing totalled 112.07m or 1,468.27% of revenues. In addition the company used 59.67m for operations while cash used for investing totalled 261.00k.
Cash flow per share | -1.24 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.57 |
---|---|
Tangible book value per share | 0.7106 |
More ▼
Balance sheet in SEKView more
Current ratio | 2.48 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0574 |
---|---|
Total debt/total capital | 0.0543 |
More ▼